These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 35851704)
1. Development and psychometric evaluation of the Aversion to Bowel Cancer Screening Scale. Davis M; Oaten M; Tapp C; Occhipinti S Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13661. PubMed ID: 35851704 [TBL] [Abstract][Full Text] [Related]
2. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514 [TBL] [Abstract][Full Text] [Related]
3. Psychometric properties of the Persian version of Champion's Health Belief Model Scale for colorectal cancer screening. Kharameh ZT; Foroozanfar S; Zamanian H Asian Pac J Cancer Prev; 2014; 15(11):4595-9. PubMed ID: 24969891 [TBL] [Abstract][Full Text] [Related]
4. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults. Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105 [TBL] [Abstract][Full Text] [Related]
5. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests. Choi E; Jeon J; Kim J Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048 [TBL] [Abstract][Full Text] [Related]
6. Validity and Reliability of the Instruments to Measure Colorectal Cancer Screening Benefits and Barriers-Turkish Version. Dönmez E; Nahcivan NO; Rawl SM Cancer Nurs; 2022 Mar-Apr 01; 45(2):E364-E373. PubMed ID: 33399288 [TBL] [Abstract][Full Text] [Related]
7. Psychometric Evaluation of the Colorectal Cancer Screening Belief Scale Based on Health Belief Model's Constructs for the Fecal Occult Blood Test. Tahmasebi R; Noroozi A; Dashdebi KG Asian Pac J Cancer Prev; 2016; 17(1):225-9. PubMed ID: 26838214 [TBL] [Abstract][Full Text] [Related]
8. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581 [TBL] [Abstract][Full Text] [Related]
9. Emotional Barriers to Bowel Screening in Italy: Scale psychometric properties and effects on screening attendance. Scaglioni G; Cavazza N Psychooncology; 2022 Jan; 31(1):78-85. PubMed ID: 34331357 [TBL] [Abstract][Full Text] [Related]
10. Psychosocial Predictors of Colorectal Cancer Screening Intention: An Experiment on the Invitation Letter. Scaglioni G; Chiereghin A; Bazzani C; Mezzetti F; Cavazza N Int J Behav Med; 2023 Dec; 30(6):867-877. PubMed ID: 36515798 [TBL] [Abstract][Full Text] [Related]
11. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake. Todorov K; Wilson C; Sharplin G; Corsini N Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632 [TBL] [Abstract][Full Text] [Related]
12. Patients' Preferences for Primary Colorectal Cancer Screening: A Survey of the National Colorectal Cancer Screening Program in Korea. Cho YH; Kim DH; Cha JM; Jeen YT; Moon JS; Kim JO; Lee SK; Cho YK; Im JP; Jang JY; Shin JE; Yoon SM; Jung Y; Kim ES; Lee KN; Cho SJ; Kim Y; Park BY Gut Liver; 2017 Nov; 11(6):821-827. PubMed ID: 28750489 [TBL] [Abstract][Full Text] [Related]
13. Early Detection of Colorectal Cancer: a Multi-Center Pre-Clinical Case Cohort Study for Validation of a Combined DNA Stool Test. Dollinger MM; Behl S; Fleig WE Clin Lab; 2018 Oct; 64(10):1719-1730. PubMed ID: 30336540 [TBL] [Abstract][Full Text] [Related]
14. Implementation intentions and colorectal screening: a randomized trial in safety-net clinics. Greiner KA; Daley CM; Epp A; James A; Yeh HW; Geana M; Born W; Engelman KK; Shellhorn J; Hester CM; LeMaster J; Buckles DC; Ellerbeck EF Am J Prev Med; 2014 Dec; 47(6):703-14. PubMed ID: 25455115 [TBL] [Abstract][Full Text] [Related]
15. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic. Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000 [TBL] [Abstract][Full Text] [Related]
16. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy? van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149 [TBL] [Abstract][Full Text] [Related]
17. Adapting Champion's Breast Cancer Fear Scale to colorectal cancer: psychometric testing in a sample of older Chinese adults. Leung DY; Wong EM; Chan CW Eur J Oncol Nurs; 2014 Jun; 18(3):281-5. PubMed ID: 24629503 [TBL] [Abstract][Full Text] [Related]
18. Consequences of screening in colorectal cancer (COS-CRC): development and dimensionality of a questionnaire. Malmqvist J; Siersma V; Bang CW; Brodersen J BMC Psychol; 2021 Jan; 9(1):7. PubMed ID: 33413695 [TBL] [Abstract][Full Text] [Related]
19. Self-perceived Mental Health Status and Uptake of Fecal Occult Blood Test for Colorectal Cancer Screening in Canada: A Cross-Sectional Study. Hategekimana C; Karamouzian M Int J Health Policy Manag; 2016 Feb; 5(6):365-71. PubMed ID: 27285514 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams. Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]